Provided by Tiger Fintech (Singapore) Pte. Ltd.

IDEAYA Biosciences

21.67
-0.1900-0.87%
Post-market: 21.670.00000.00%16:20 EDT
Volume:780.06K
Turnover:16.94M
Market Cap:1.90B
PE:-6.00
High:22.01
Open:22.00
Low:21.31
Close:21.86
Loading ...

IDEAYA Biosciences Launching Gilead Trial Collaboration to Evaluate Trodelvy, IDE397 Combination in Lung Cancer

MT Newswires Live
·
13 Feb

IDEAYA Biosciences Shares Fall 4.3% After Q4 Results

THOMSON REUTERS
·
13 Feb

IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss

Zacks
·
13 Feb

IDEAYA Biosciences Q4 Loss Widens, Revenue Rises

MT Newswires Live
·
13 Feb

IDEAYA Biosciences- About $1.1 Bln Cash Equivalents as of Dec 31, 2024, Anticipated to Fund Operations Into at Least 2028

THOMSON REUTERS
·
13 Feb

Earnings Flash (IDYA) IDEAYA Biosciences Posts Q4 Collaboration Revenue of $7M

MT Newswires Live
·
13 Feb

Earnings Flash (IDYA) IDEAYA Biosciences Posts Q4 Net Loss $-1.49 per Share, vs. FactSet Est of $-0.64 Loss

MT Newswires Live
·
13 Feb

IDEAYA Biosciences Shares up 3.8% Premarket After Q4 Results

THOMSON REUTERS
·
13 Feb

IDEAYA Biosciences Q4 2024 GAAP EPS $(1.49) Misses $(0.64) Estimate, Sales $7.00M Beat $4.67M Estimate

Benzinga
·
13 Feb

IDEAYA Biosciences Q4 Profit From Operations USD -144.138 Million

THOMSON REUTERS
·
13 Feb

IDEAYA Biosciences Q4 Collaboration Revenue USD 7 Million

THOMSON REUTERS
·
13 Feb

IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

PR Newswire
·
13 Feb

IDEAYA Announces Further Gilead Sciences Clinical Study Collaboration Evaluating Combination of Trodelvy® and Ide397 in Mtap-Deletion Nsclc

THOMSON REUTERS
·
13 Feb

IDEAYA Biosciences Inc: IDEAYA Is Study Sponsor and Gilead Will Provide Supply of Trodelvy to IDEAYA

THOMSON REUTERS
·
13 Feb

IDEAYA Biosciences Inc: IDEAYA and Gilead Retain Commercial Rights to Their Respective Compounds

THOMSON REUTERS
·
13 Feb

IDEAYA Announces Further Gilead Sciences Clinical Study Collaboration Evaluating Combination of Trodelvy® and IDE397 in MTAP-Deletion NSCLC

PR Newswire
·
13 Feb

All You Need to Know About IDEAYA Biosciences (IDYA) Rating Upgrade to Buy

Zacks
·
11 Feb

IDEAYA Biosciences Taps J.P. Morgan Exec for CFO

Dow Jones
·
10 Feb

IDEAYA Biosciences Appoints Joshua Bleharski as Finance Chief

MT Newswires Live
·
10 Feb

IDEAYA Biosciences Announces Appointment of Healthcare Investment Banking Veteran Joshua Bleharski as Chief Financial Officer

THOMSON REUTERS
·
10 Feb